ATHE Positive Sentiment Score: 70/100
Results of Extraordinary General Meeting MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA - 12 April 2024 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") advises that all resolutions considered at
Friday, April 12, 2024 1 min read
Key Takeaway: Alterity Therapeutics held an Extraordinary General Meeting on April 12, 2024, in which all resolutions were voted on and passed by poll. This outcome indicates strong support from shareholders and signals a positive direction for the company's corporate governance. Details regarding the proxies received and votes cast have been provided in accordance with regulatory requirements. The approval reflects the commitment of Alterity to maintain transparency and compliance.
Full Press Release Details
Results of Extraordinary General
MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA -
12 April 2024 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") advises that
all resolutions considered at the Extraordinary General Meeting held today were carried by poll.
In accordance with ASX Listing rule 3.13.2 and Section
251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Alterity Therapeutics Limited
Level 3, 62 Lygon Street Carlton